The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapy
- 1 December 1999
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 45 (5), 1235-1238
- https://doi.org/10.1016/s0360-3016(99)00321-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Prostate-Specific Antigen Levels are Higher in African-American Than in White Patients in a Multicenter Registration Study: Results of RTOG 94-12International Journal of Radiation Oncology*Biology*Physics, 1998
- Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancerThe Prostate, 1997
- Prostate-Specific Antigen (PSA) and PSA Density: Racial Differences in Men Without Prostate CancerJNCI Journal of the National Cancer Institute, 1997
- Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black MenNew England Journal of Medicine, 1996
- Black Race is an Adverse Prognostic Factor for Prostate Cancer Recurrence Following Radical Prostatectomy in an Equal Access Health Care SettingJournal of Urology, 1996
- Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screeningUrology, 1995
- Receptivity of african-american men to prostate cancer screeningUrology, 1994
- The Frequency of Carcinoma and Intraepithelial Neoplasia of the Prostate in Young Male PatientsJournal of Urology, 1993
- The prognostic significance of race and survival from prostate cancer based on patients irradiated on radiation therapy oncology group protocols (1976–1985)International Journal of Radiation Oncology*Biology*Physics, 1992
- Radiation-Treated Carcinoma of Prostate Comparison of Survival of Black and White Patients by Gleasonʼs Grading SystemAmerican Journal of Clinical Oncology, 1988